Press coverage about Health Insurance Innovations (NASDAQ:HIIQ) has trended positive on Thursday, according to Accern Sentiment Analysis. The research firm identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Health Insurance Innovations earned a media sentiment score of 0.50 on Accern’s scale. Accern also assigned news headlines about the financial services provider an impact score of 50 out of 100, meaning that recent news coverage is somewhat likely to have an effect on the company’s share price in the near future.

These are some of the news headlines that may have impacted Accern’s scoring:

Shares of Health Insurance Innovations (HIIQ) traded up 9.63% during trading on Thursday, reaching $29.60. The company’s stock had a trading volume of 980,865 shares. The stock has a 50 day moving average of $25.25 and a 200-day moving average of $20.08. The company has a market capitalization of $372.96 million, a PE ratio of 28.74 and a beta of 0.67. Health Insurance Innovations has a 1-year low of $3.90 and a 1-year high of $30.50.

Health Insurance Innovations (NASDAQ:HIIQ) last posted its earnings results on Wednesday, August 2nd. The financial services provider reported $0.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.33 by $0.13. Health Insurance Innovations had a return on equity of 20.05% and a net margin of 4.77%. The firm had revenue of $61.80 million for the quarter, compared to analyst estimates of $53.69 million. The business’s revenue was up 38.9% on a year-over-year basis. On average, analysts expect that Health Insurance Innovations will post $1.44 earnings per share for the current year.

Several equities research analysts have commented on the stock. Craig Hallum reiterated a “buy” rating and set a $38.00 price target (up from $28.00) on shares of Health Insurance Innovations in a research report on Thursday. Cantor Fitzgerald reissued an “overweight” rating and set a $35.00 price objective (up previously from $30.00) on shares of Health Insurance Innovations in a research note on Monday, July 17th. Raymond James Financial, Inc. reaffirmed a “market perform” rating on shares of Health Insurance Innovations in a research note on Monday, June 26th. Canaccord Genuity reissued a “buy” rating and set a $30.00 price objective on shares of Health Insurance Innovations in a research report on Thursday, July 13th. Finally, Zacks Investment Research downgraded Health Insurance Innovations from a “buy” rating to a “hold” rating in a report on Wednesday, July 12th. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $28.33.

WARNING: This piece of content was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://www.thecerbatgem.com/2017/08/03/health-insurance-innovations-nasdaqhiiq-receiving-favorable-media-coverage-accern-reports-updated-updated-updated.html.

In other news, CEO Bruce Telkamp sold 3,901 shares of the stock in a transaction dated Friday, May 26th. The shares were sold at an average price of $22.60, for a total transaction of $88,162.60. Following the transaction, the chief executive officer now owns 107,071 shares of the company’s stock, valued at $2,419,804.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Sheldon Wang sold 24,750 shares of the firm’s stock in a transaction dated Friday, May 5th. The stock was sold at an average price of $19.73, for a total transaction of $488,317.50. Following the completion of the transaction, the insider now directly owns 236,001 shares in the company, valued at approximately $4,656,299.73. The disclosure for this sale can be found here. Insiders sold a total of 261,733 shares of company stock worth $6,240,713 over the last ninety days. Corporate insiders own 30.00% of the company’s stock.

Health Insurance Innovations Company Profile

Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.

Insider Buying and Selling by Quarter for Health Insurance Innovations (NASDAQ:HIIQ)

Receive News & Stock Ratings for Health Insurance Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations Inc. and related stocks with our FREE daily email newsletter.